Patents for C12R 1 - Micro-organisms (92,025) |
---|
03/09/2000 | WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
03/09/2000 | WO2000012688A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene |
03/09/2000 | WO2000012684A2 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus |
03/09/2000 | WO2000012561A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same |
03/09/2000 | WO2000012559A1 Monoclonal antibodies against s100 |
03/09/2000 | WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3 |
03/09/2000 | WO2000012546A1 MAMMALIAN elk POTASSIUM CHANNEL GENES |
03/09/2000 | WO2000012535A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
03/09/2000 | WO2000012140A1 Method for labeling biopolymers using isotopes |
03/09/2000 | WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof |
03/09/2000 | WO2000012129A2 Salmonella typhi vaccine compositions |
03/09/2000 | WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions |
03/09/2000 | WO1999058686A3 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b12 transport |
03/09/2000 | WO1999050397A3 Immobilized nuclease from serratia marcescens |
03/09/2000 | DE4090565C2 Rekombinantes Herpesvirus-Pockenvirus-Vakzin A recombinant herpesvirus poxvirus vaccine |
03/09/2000 | DE19839567A1 Organismen zur extrazellulären Herstellung von Riboflavin Organisms for the extracellular production of riboflavin |
03/09/2000 | CA2633074A1 Elongase genes and uses thereof |
03/09/2000 | CA2344591A1 Methods for improving the function of heterologous g protein-coupled receptors |
03/09/2000 | CA2343046A1 Enhanced functional expression of g protein-coupled receptors |
03/09/2000 | CA2342534A1 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
03/09/2000 | CA2341766A1 Mammalian elk potassium channel genes |
03/09/2000 | CA2341715A1 Organisms for the extracellular production of riboflavin |
03/09/2000 | CA2341703A1 Salmonella typhi vaccine compositions |
03/09/2000 | CA2341627A1 Method for assessing the relative purity of viral gene transfer vector stocks |
03/09/2000 | CA2341554A1 Process for the preparation of (2r)-piperidine derivatives |
03/09/2000 | CA2341324A1 Transgene assay using stable agrobacterium rhizogenes transformation |
03/09/2000 | CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3 |
03/09/2000 | CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes |
03/09/2000 | CA2340937A1 A new method of identifying non-host plant disease resistance genes |
03/09/2000 | CA2340462A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene |
03/09/2000 | CA2340276A1 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences |
03/09/2000 | CA2337869A1 Method for labeling biopolymers using isotopes |
03/09/2000 | CA2336961A1 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus |
03/09/2000 | CA2281035A1 Dsba/dsbb/dsbc/dsbd expression plasmid |
03/08/2000 | EP0984062A1 Production of human erythropoietin |
03/08/2000 | EP0984061A1 Sialidases localized on plasma membranes and dna encoding the same |
03/08/2000 | EP0984023A1 Cell surface molecule mediating cell adhesion and signal transmission |
03/08/2000 | EP0983364A1 Dna polymerases having improved labeled nucleotide incorporation properties |
03/08/2000 | EP0983361A1 Bacterial pheromones and uses therefor |
03/08/2000 | EP0983354A2 Neurotrophic factor receptors |
03/08/2000 | EP0983343A1 E. coli, salmonella or hafnia autoinducers |
03/08/2000 | EP0983342A1 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin |
03/08/2000 | EP0983297A1 New echinocandine derivatives with antimicrobial activity |
03/08/2000 | EP0804596A4 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4 |
03/08/2000 | EP0722501B1 Cloned pullulanase |
03/08/2000 | EP0672136B1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
03/08/2000 | EP0669970B1 Degradation of nucleic acids by peroxides |
03/08/2000 | EP0619843B1 Icams immunoglobulin constant region soluble fusion proteins |
03/08/2000 | CN1246893A Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides spp |
03/08/2000 | CN1050153C Process for production of biotin, mini-bacillus genus microbe and its application |
03/07/2000 | US6034222 Method for the separation of recombinant pro-factor IX from recombinant factor IX |
03/07/2000 | US6034124 Bactericides |
03/07/2000 | US6034107 5-Substituted picolinic acid compounds and their production process |
03/07/2000 | US6034061 Forming chondrocyte tissue in animal; administering bone morphogenic protein |
03/07/2000 | US6034060 Peptide having an ability to promote the activation of protein C by thrombin |
03/07/2000 | US6033903 Method of expressing and secreting soluble extracellular domains of human gonadotropin hormone receptors |
03/07/2000 | US6033900 The use of a rhamnogalacturonase for degradation or modification of plant cell materials for increasing digestablility of animal feeds. |
03/07/2000 | US6033890 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases |
03/07/2000 | US6033883 Production of polyketides in bacteria and yeast |
03/07/2000 | US6033882 Chiral synthesis of 2-hydroxy carboxylic acids with a dehydrogenase |
03/07/2000 | US6033879 Process for the preparation of substituted aryl lactic acid containing cyclodepsipeptides with 24 ring atoms |
03/07/2000 | US6033874 CRY1C polypeptides having improved toxicity to lepidopteran insects |
03/07/2000 | US6033865 Human n-methyl-d-aspartate receptor type 1 subunits, DNA encoding same and uses therefor |
03/07/2000 | US6033863 Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids |
03/07/2000 | US6033856 Promoter of the cdc25B gene, its preparation and use |
03/07/2000 | US6033823 Mutated penicillin G acylase genes |
03/07/2000 | CA1340919C Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests |
03/02/2000 | WO2000011202A1 Cationic complexes of polymer-modified adenovirus |
03/02/2000 | WO2000011201A1 Targeted alphavirus and alphaviral vectors |
03/02/2000 | WO2000011196A1 Polynucleotide sequences |
03/02/2000 | WO2000011188A1 Transgenic microbial polyhydroxyalkanoate producers |
03/02/2000 | WO2000011175A1 Genetic method for the expression of polyproteins in plants |
03/02/2000 | WO2000011169A2 Human cell signaling proteins (csig) |
03/02/2000 | WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
03/02/2000 | WO2000011163A1 Dcr5, a bmp-binding protein, and applications thereof |
03/02/2000 | WO2000011154A1 USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS |
03/02/2000 | WO2000011152A1 Streptavidin mutants having secondary functional domains |
03/02/2000 | WO2000011144A2 Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof |
03/02/2000 | WO2000011139A1 Cell population containing non-fetal hemangioblasts and method for producing same |
03/02/2000 | WO2000011037A1 Monoclonal antibodies specific for streptococcus mutans, and uses thereof |
03/02/2000 | WO2000011036A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
03/02/2000 | WO2000010989A1 Process for the preparation of c-4 deacetyltaxanes |
03/02/2000 | WO2000010593A1 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS |
03/02/2000 | WO2000010584A1 Method for detection of legionella bacteria employing purified antigen-specific antibodies |
03/02/2000 | WO2000010582A2 Probiotic, lactic acid-producing bacteria and uses thereof |
03/02/2000 | WO2000010380A1 Manipulation of tocopherol levels in transgenic plants |
03/02/2000 | WO1999064619A3 Novel mannanases |
03/02/2000 | WO1999063090A3 Protease inhibitor peptides |
03/02/2000 | WO1999061604A3 A vector for gene trap, and a method for gene trapping by using the vector |
03/02/2000 | WO1999057261A3 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
03/02/2000 | DE19839491A1 Verfahren zur Markierung von Biopolymeren mit Isotopen Methods for labeling of biopolymers with isotopes |
03/02/2000 | CA2341516A1 Cationic complexes of polymer-modified adenovirus |
03/02/2000 | CA2340857A1 Manipulation of tocopherol levels in transgenic plants |
03/02/2000 | CA2340787A1 An anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
03/02/2000 | CA2340595A1 Streptavidin mutants having secondary functional domains |
03/02/2000 | CA2340471A1 Process for the preparation of c-4 deacetyltaxanes |
03/02/2000 | CA2340335A1 Use of suppressor trna's to regulate cytotoxicity during the production of recombinant gene products |
03/02/2000 | CA2339968A1 Dcr5, a bmp-binding protein, and applications thereof |
03/02/2000 | CA2339871A1 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
03/02/2000 | CA2339860A1 Human cell signaling proteins (csig) |